Market Share of Russia Insulin Drugs and Delivery Devices Industry
Russia Insulin Drugs and Delivery Devices Market is consolidated, with few significant and generic players. Mergers and acquisitions that happened between the players in the recent past have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim together have an alliance in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.
Russia Insulin Drugs & Delivery Devices Market Leaders
-
Roche
-
Medtronics
-
Novo Nordisk
-
Eli Lilly
-
Sanofi
*Disclaimer: Major Players sorted in no particular order
